340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the Department of Health and Human Services’ 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.
The AHA today voiced support for the 340B Rebate Model Delay Act (H.R. 10770) in a letter to the bill’s House sponsors.
The American Hospital Association voices support of the 340B Rebate Model Delay Act (H.R. 10770).
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging changes by the Department of Health and Human Services to the 340B Drug Pricing Program that would expand the use of a proposed rebate model…
AHA, MHA, and four safety-net hospitals filed a motion for a temporary restraining order to stop the costly 340B rebate program that will force hospitals providing care to America’s most vulnerable patients to spend billions on administrative costs.
The AHA, the Maine Hospital Association and four safety-net hospitals today filed a lawsuit in the U.S. District Court for the District of Maine challenging changes by the HHS to the 340B Drug Pricing Program that would expand the use of a proposed rebate model previously halted by the courts.
The revised 340B rebate program will force hospitals providing care to America’s most vulnerable patients to spend billions on administrative costs, repeating the same flaws courts previously identified.
AHA, MHA, and four safety-net hospitals file suit to stop costly 340B rebate program that will force hospitals providing care to America’s most vulnerable patients to spend billions on administrative costs.
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a preliminary injunction against Eli Lilly’s new 340B claims data policy.